Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL140261,HL136813,HL091842,HL051670
Cystic Fibrosis Foundation
Grant: Cystic Fibrosis Foundation Research Development Program (RDP)
Vertex Pharmaceuticals
Grant: Vertex Investigator-Initiated Studies Program
Cystic Fibrosis Foundation
Grant: CFF RDP pilot grant
Gilead Sciences
Grant: Gilead Sciences Research Scholars Program
Howard Hughes Medical Institute
Grant: Principal Investigator
NHLBI NIH HHS
Grant: K01 HL140261
NHLBI NIH HHS
Grant: P01 HL152960
NHLBI NIH HHS
Grant: K24 HL102246
NHLBI NIH HHS
Grant: P01 HL051670
NHLBI NIH HHS
Grant: R01 HL136813
NIDDK NIH HHS
Grant: P30 DK054759
NHLBI NIH HHS
Grant: P01 HL091842
Howard Hughes Medical Institute
Howard Hughes Medical Institute
FWCI
5.61
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords